BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
2901
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $121K | ﹤0.01% |
8,415
+2,442
| +41% | +$34.9K |
|
|
CMO
2902
DELISTED
Capstead Mortgage Corp.
CMO
| $121K | ﹤0.01% |
16,426
-6,280
| -28% | -$50.4K |
|
2903
TTEC Holdings
TTEC
$77.4M
| $120K | ﹤0.01% |
2,511
+436
| +21% | +$20.4K |
|
2904
NRC Health Common Stock
NRC
$471M
| $120K | ﹤0.01% |
2,070
+737
| +55% | +$45.7K |
|
2905
Par Pacific Holdings
PARR
$4.12B
| $119K | ﹤0.01% |
5,227
+1,628
| +45% | +$36K |
|
|
BFS
2906
Saul Centers
BFS
$865M
| $119K | ﹤0.01% |
2,191
+668
| +44% | +$35.6K |
|
2907
Tactile Systems Technology
TCMD
$537M
| $119K | ﹤0.01% |
2,819
+707
| +33% | +$36.5K |
|
|
VCRA
2908
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $119K | ﹤0.01% |
4,827
+1,306
| +37% | +$33.9K |
|
2909
Tootsie Roll Industries
TR
$3.02B
| $119K | ﹤0.01% |
3,936
+1,516
| +63% | +$45.7K |
|
2910
Onto Innovation
ONTO
$20.6B
| $119K | ﹤0.01% |
3,643
-1,332
| -27% | -$41.5K |
|
2911
Ares Capital
ARCC
$14.5B
| $119K | ﹤0.01% |
6,376
-6,562
| -51% | -$122K |
|
2912
TherapeuticsMD
TXMD
$24.1M
| $119K | ﹤0.01% |
654
+195
| +42% | +$27.5K |
|
2913
MGP Ingredients
MGPI
$389M
| $119K | ﹤0.01% |
2,386
+514
| +27% | +$28.8K |
|
|
RARX
2914
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $118K | ﹤0.01% |
5,003
+2,901
| +138% | +$86K |
|
2915
Stellantis
STLA
$20.2B
| $118K | ﹤0.01% |
9,130
+2,717
| +42% | +$36.4K |
|
2916
Preferred Bank
PFBC
$1.28B
| $118K | ﹤0.01% |
2,254
+695
| +45% | +$35.4K |
|
2917
Upland Software
UPLD
$17.9M
| $118K | ﹤0.01% |
338
+149
| +79% | +$61.9K |
|
2918
Alaunos Therapeutics
TCRT
$4.86M
| $117K | ﹤0.01% |
183
+70
| +62% | +$55.5K |
|
2919
Washington Trust Bancorp
WASH
$767M
| $117K | ﹤0.01% |
2,426
-94
| -4% | -$4.6K |
|
2920
Univest Financial
UVSP
$1.19B
| $117K | ﹤0.01% |
4,582
+1,368
| +43% | +$35.4K |
|
2921
Gossamer Bio
GOSS
$83.3M
| $117K | ﹤0.01% |
6,959
+5,087
| +272% | +$101K |
|
2922
WisdomTree
WT
$3.44B
| $117K | ﹤0.01% |
22,360
+1,613
| +8% | +$9.12K |
|
2923
Madrigal Pharmaceuticals
MDGL
$11.7B
| $116K | ﹤0.01% |
1,345
+370
| +38% | +$34.7K |
|
2924
Trupanion
TRUP
$1.36B
| $116K | ﹤0.01% |
4,549
+1,534
| +51% | +$44.9K |
|
|
TEN
2925
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $116K | ﹤0.01% |
9,232
-2,676
| -22% | -$27.3K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.